Developmental Regulation of NO-Mediated VEGF-Induced Effects in the Lung
- 1 October 2008
- journal article
- Published by American Thoracic Society in American Journal of Respiratory Cell and Molecular Biology
- Vol. 39 (4), 420-430
- https://doi.org/10.1165/rcmb.2007-0024oc
Abstract
Vascular endothelial growth factor (VEGF) is known to have a pivotal role in lung development and in a variety of pathologic conditions in the adult lung. Our earlier studies have shown that NO is a critical mediator of VEGF-induced vascular and extravascular effects in the adult murine lung. As significant differences have been reported in the cytokine responses in the adult versus the neonatal lung, we hypothesized that there may be significant differences in VEGF-induced alterations in the developing as opposed to the mature lung. Furthermore, nitric oxide (NO) mediation of these VEGF-induced effects may be developmentally regulated. Using a novel externally regulatable lung-targeted transgenic murine model, we found that VEGF-induced pulmonary hemorrhage was mediated by NO-dependent mechanisms in adults and newborns. VEGF enhanced surfactant production in adults as well as increased surfactant and lung development in newborns, via an NO-independent mechanism. While the enhanced survival in hyperoxia in the adult was partly NO-dependent, there was enhanced hyperoxia-induced lung injury in the newborn. In addition, human amniotic fluid VEGF levels correlated positively with surfactant phospholipids. Tracheal aspirate VEGF levels had an initial spike, followed by a decline, and then a subsequent rise, in human neonates with an outcome of bronchopulmonary dysplasia or death. Our data show that VEGF can have injurious as well as potentially beneficial developmental effects, of which some are NO dependent, others NO independent. This opens up the possibility of selective manipulation of any VEGF-based intervention using NO inhibitors for maximal potential clinical benefit.Keywords
This publication has 63 references indexed in Scilit:
- Coordinate release of angiogenic growth factors after acute myocardial infarction: evidence of a two-wave productionJournal of Cardiovascular Medicine, 2006
- Strain Differences Influence Murine Pulmonary Responses toStachybotrys chartarumAmerican Journal of Respiratory Cell and Molecular Biology, 2006
- Essential role of nitric oxide in VEGF-induced, asthma-like angiogenic, inflammatory, mucus, and physiologic responses in the lungProceedings of the National Academy of Sciences of the United States of America, 2006
- Vascular endothelial growth factor (VEGF) in acute lung injury (ALI) and acute respiratory distress syndrome (ARDS): paradox or paradigm?Thorax, 2006
- Strain-specific differences in sensitivity to ischemia-reperfusion lung injury in miceJournal of Applied Physiology, 2006
- Role of Angiogenesis in Cardiovascular DiseaseCirculation, 2005
- Angiogenic factors are elevated in overweight and obese individualsInternational Journal of Obesity, 2005
- Effects of vascular endothelial growth factor on isolated fetal alveolar type II cellsAmerican Journal of Physiology-Lung Cellular and Molecular Physiology, 2004
- The biology of VEGF and its receptorsNature Medicine, 2003
- Regulated overexpression of interleukin 11 in the lung. Use to dissociate development-dependent and -independent phenotypes.JCI Insight, 1997